These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26888941)

  • 1. The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy.
    Eng H; Scialis RJ; Rotter CJ; Lin J; Lazzaro S; Varma MV; Di L; Feng B; West M; Kalgutkar AS
    Drug Metab Dispos; 2016 May; 44(5):692-9. PubMed ID: 26888941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.
    Gupta A; Harris JJ; Lin J; Bulgarelli JP; Birmingham BK; Grimm SW
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5986-94. PubMed ID: 27458210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
    Kindla J; Müller F; Mieth M; Fromm MF; König J
    Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.
    Elsby R; Martin P; Surry D; Sharma P; Fenner K
    Drug Metab Dispos; 2016 Mar; 44(3):398-408. PubMed ID: 26700956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.
    Neuvonen PJ; Niemi M; Backman JT
    Clin Pharmacol Ther; 2006 Dec; 80(6):565-81. PubMed ID: 17178259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.
    Chen C; Mireles RJ; Campbell SD; Lin J; Mills JB; Xu JJ; Smolarek TA
    Drug Metab Dispos; 2005 Apr; 33(4):537-46. PubMed ID: 15616150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis.
    Lapham K; Novak J; Marroquin LD; Swiss R; Qin S; Strock CJ; Scialis R; Aleo MD; Schroeter T; Eng H; Rodrigues AD; Kalgutkar AS
    Chem Res Toxicol; 2016 Oct; 29(10):1778-1788. PubMed ID: 27676153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.
    Balasubramanian R; Maideen NMP
    Curr Drug Metab; 2021; 22(5):328-341. PubMed ID: 33459228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.
    Lee HH; Leake BF; Kim RB; Ho RH
    Mol Pharmacol; 2017 Jan; 91(1):14-24. PubMed ID: 27777271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions.
    Alam K; Pahwa S; Wang X; Zhang P; Ding K; Abuznait AH; Li L; Yue W
    Mol Pharm; 2016 Mar; 13(3):839-51. PubMed ID: 26750564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters.
    Chu X; Cai X; Cui D; Tang C; Ghosal A; Chan G; Green MD; Kuo Y; Liang Y; Maciolek CM; Palamanda J; Evers R; Prueksaritanont T
    Drug Metab Dispos; 2013 Mar; 41(3):668-81. PubMed ID: 23293300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results From Drug-Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3.
    Heinig R; Fricke R; Wertz S; Nagelschmitz J; Loewen S
    Eur J Drug Metab Pharmacokinet; 2022 Nov; 47(6):803-815. PubMed ID: 36029368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin.
    Kitamura S; Maeda K; Wang Y; Sugiyama Y
    Drug Metab Dispos; 2008 Oct; 36(10):2014-23. PubMed ID: 18617601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3.
    Seithel A; Eberl S; Singer K; Auge D; Heinkele G; Wolf NB; Dörje F; Fromm MF; König J
    Drug Metab Dispos; 2007 May; 35(5):779-86. PubMed ID: 17296622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.
    Amundsen R; Christensen H; Zabihyan B; Asberg A
    Drug Metab Dispos; 2010 Sep; 38(9):1499-504. PubMed ID: 20519340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of organic anion-transporting polypeptides in the hepatic uptake of dioscin in rats and humans.
    Zhang A; Wang C; Liu Q; Meng Q; Peng J; Sun H; Ma X; Huo X; Liu K
    Drug Metab Dispos; 2013 May; 41(5):994-1003. PubMed ID: 23396419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1.
    Elsby R; Hare V; Neal H; Outteridge S; Pearson C; Plant K; Gill RU; Butler P; Riley RJ
    Drug Metab Dispos; 2019 Jan; 47(1):1-8. PubMed ID: 30348903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.
    Niemi M; Pasanen MK; Neuvonen PJ
    Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.